Canada · Delayed Price · Currency is CAD Microbix Biosystems Statistics
Total Valuation
TSX:MBX has a market cap or net worth of CAD 43.83 million. The enterprise value is 43.39 million.
| Market Cap | 43.83M |
| Enterprise Value | 43.39M |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MBX has 136.97 million shares outstanding. The number of shares has decreased by -1.62% in one year.
| Current Share Class | 136.97M |
| Shares Outstanding | 136.97M |
| Shares Change (YoY) | -1.62% |
| Shares Change (QoQ) | -0.83% |
| Owned by Insiders (%) | 16.65% |
| Owned by Institutions (%) | n/a |
| Float | 114.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.85 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.89, with a Debt / Equity ratio of 0.28.
| Current Ratio | 6.89 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.73 |
| Interest Coverage | -4.22 |
Financial Efficiency
Return on equity (ROE) is -18.24% and return on invested capital (ROIC) is -17.96%.
| Return on Equity (ROE) | -18.24% |
| Return on Assets (ROA) | -7.39% |
| Return on Invested Capital (ROIC) | -17.96% |
| Return on Capital Employed (ROCE) | -13.80% |
| Weighted Average Cost of Capital (WACC) | 8.00% |
| Revenue Per Employee | 154,002 |
| Profits Per Employee | -48,849 |
| Employee Count | 100 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 0.86 |
Taxes
| Income Tax | -55,726 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.33% in the last 52 weeks. The beta is 0.57, so TSX:MBX's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +33.33% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 59.33 |
| Average Volume (20 Days) | 32,055 |
Short Selling Information
The latest short interest is 11,447, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 11,447 |
| Short Previous Month | 4,761 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:MBX had revenue of CAD 15.40 million and -4.88 million in losses. Loss per share was -0.04.
| Revenue | 15.40M |
| Gross Profit | 7.07M |
| Operating Income | -4.28M |
| Pretax Income | -4.94M |
| Net Income | -4.88M |
| EBITDA | -3.06M |
| EBIT | -4.28M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 7.16 million in cash and 6.72 million in debt, with a net cash position of 440,066 or 0.00 per share.
| Cash & Cash Equivalents | 7.16M |
| Total Debt | 6.72M |
| Net Cash | 440,066 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 24.26M |
| Book Value Per Share | 0.18 |
| Working Capital | 18.09M |
Cash Flow
In the last 12 months, operating cash flow was -3.29 million and capital expenditures -595,172, giving a free cash flow of -3.89 million.
| Operating Cash Flow | -3.29M |
| Capital Expenditures | -595,172 |
| Depreciation & Amortization | 1.22M |
| Net Borrowing | -275,693 |
| Free Cash Flow | -3.89M |
| FCF Per Share | -0.03 |
Margins
Gross margin is 45.90%, with operating and profit margins of -27.77% and -31.72%.
| Gross Margin | 45.90% |
| Operating Margin | -27.77% |
| Pretax Margin | -32.08% |
| Profit Margin | -31.72% |
| EBITDA Margin | -19.84% |
| EBIT Margin | -27.77% |
| FCF Margin | n/a |
Dividends & Yields
TSX:MBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.62% |
| Shareholder Yield | 1.62% |
| Earnings Yield | -11.15% |
| FCF Yield | -8.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSX:MBX has an Altman Z-Score of 1.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.22 |
| Piotroski F-Score | 1 |